NCT03489993View on ClinicalTrials.gov

FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions
HypophosphatemiaX-linked HypophosphatemiaRenin-angiotensin SystemLeft Ventricular Hypertrophy
Interventions
DIAGNOSTIC_TEST

Ang II and Ang-(1-7)

Measured in plasma and urine using radioimmunoassays.

DIAGNOSTIC_TEST

FGF23 and klotho

Measured using ELISA's.

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03489993 - FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) | Biotech Hunter | Biotech Hunter